These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1723078)

  • 21. Convergent structural features of respiratory syncytial virus neutralizing antibodies and plasticity of the site V epitope on prefusion F.
    Harshbarger W; Tian S; Wahome N; Balsaraf A; Bhattacharya D; Jiang D; Pandey R; Tungare K; Friedrich K; Mehzabeen N; Biancucci M; Chinchilla-Olszar D; Mallett CP; Huang Y; Wang Z; Bottomley MJ; Malito E; Chandramouli S
    PLoS Pathog; 2020 Nov; 16(11):e1008943. PubMed ID: 33137810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses.
    Palomo C; Mas V; Thom M; Vázquez M; Cano O; Terrón MC; Luque D; Taylor G; Melero JA
    J Virol; 2016 Jun; 90(11):5485-5498. PubMed ID: 27009962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus.
    Bourgeois C; Corvaisier C; Bour JB; Kohli E; Pothier P
    J Gen Virol; 1991 May; 72 ( Pt 5)():1051-8. PubMed ID: 2033389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults.
    Ye X; Iwuchukwu OP; Avadhanula V; Aideyan LO; McBride TJ; Ferlic-Stark LL; Patel KD; Piedra FA; Shah DP; Chemaly RF; Piedra PA
    Front Immunol; 2019; 10():706. PubMed ID: 30984206
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of antigenic sites of subtype-specific respiratory syncytial virus attachment proteins.
    Walsh EE; Hall CB; Schlesinger JJ; Brandriss MW; Hildreth S; Paradiso P
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2953-61. PubMed ID: 2479715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes.
    Bukreyev A; Yang L; Fricke J; Cheng L; Ward JM; Murphy BR; Collins PL
    J Virol; 2008 Dec; 82(24):12191-204. PubMed ID: 18842713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogen.
    Sesterhenn F; Galloux M; Vollers SS; Csepregi L; Yang C; Descamps D; Bonet J; Friedensohn S; Gainza P; Corthésy P; Chen M; Rosset S; Rameix-Welti MA; Éléouët JF; Reddy ST; Graham BS; Riffault S; Correia BE
    PLoS Biol; 2019 Feb; 17(2):e3000164. PubMed ID: 30789898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibody based in vitro potency assay as a predictor of antigenic integrity and in vivo immunogenicity of a Respiratory Syncytial Virus post-fusion F-protein based vaccine.
    Djagbare MD; Yu L; Parupudi A; Sun J; Coughlin ML; Rush BS; Sanyal G
    Vaccine; 2018 Mar; 36(12):1673-1680. PubMed ID: 29456016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A neutralizing monoclonal antibody to respiratory syncytial virus which binds to both F1 and F2 components of the fusion protein.
    Samson AC; Willcocks MM; Routledge EG; Morgan LA; Toms GL
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1479-83. PubMed ID: 3755162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice.
    Bian C; Liu S; Liu N; Zhang G; Xing L; Song Y; Duan Y; Gu H; Zhou Y; Zhang P; Li Z; Zhang K; Wang Z; Zhang S; Wang X; Yang P
    Antiviral Res; 2014 Apr; 104():110-7. PubMed ID: 24509239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunovirological studies on human respiratory syncytial virus structural proteins.
    Trudel M; Nadon F; Séguin C; Ghoubril S; Payment P; Trépanier P
    Can J Microbiol; 1986 Jan; 32(1):15-21. PubMed ID: 2421860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal capture antibody ELISA for respiratory syncytial virus: detection of individual viral antigens and determination of monoclonal antibody specificities.
    Hendry RM; Fernie BF; Anderson LJ; Godfrey E; McIntosh K
    J Immunol Methods; 1985 Mar; 77(2):247-58. PubMed ID: 3981003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The selection and performance of monoclonal and polyclonal anti-respiratory syncytial virus (RS) antibodies in capture ELISAs for antigen detection.
    Clayton AL; Albert ZI; Chantler SM
    J Virol Methods; 1987 Sep; 17(3-4):247-61. PubMed ID: 3316261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes.
    Fedechkin SO; George NL; Nuñez Castrejon AM; Dillen JR; Kauvar LM; DuBois RM
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental polyvalent ISCOMs subunit vaccine induces antibodies that neutralize human and bovine respiratory syncytial virus.
    Trudel M; Nadon F; Séguin C; Simard C; Lussier G
    Vaccine; 1989 Feb; 7(1):12-6. PubMed ID: 2718604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
    Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
    Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development and properties of neutralizing monoclonal antibodies for fusion protein of respiratory syncytial virus.].
    Kushch AA; Klimova RR; Fedorova NE; Masalova OV; Niconova AA; Lesnova EI; Momotyuk ED; Demidova NA; Samartseva TG; Zverev VV
    Vopr Virusol; 2019; 64(2):90-96. PubMed ID: 31412175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of subgroups of bovine respiratory syncytial virus.
    Baker JC; Wilson EG; McKay GL; Stanek RJ; Underwood WJ; Velicer LF; Mufson MA
    J Clin Microbiol; 1992 May; 30(5):1120-6. PubMed ID: 1583108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of T-cell epitopes adjacent to neutralizing antigenic domains on the fusion protein of respiratory syncytial virus.
    Corvaisier C; Guillemin G; Bourgeois C; Bour JB; Kohli E; Pothier P
    Res Virol; 1993; 144(2):141-50. PubMed ID: 7685537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.
    Anderson LJ; Hierholzer JC; Tsou C; Hendry RM; Fernie BF; Stone Y; McIntosh K
    J Infect Dis; 1985 Apr; 151(4):626-33. PubMed ID: 2579169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.